US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73

+1.431.47%

Post-market: 98.69-0.0465-0.05%19:30 EDT

Volume:7K

Turnover:644.33K

Market Cap:406.77M

PE:55.06

High:98.82

Open:97.68

Low:97.68

Close:97.30

52wk High:98.82

52wk Low:67.56

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.28

T/O Rate:0.16%

Dividend:1.55

Dividend Rate:1.57%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.64

PE(LYR):5.29

Loading ...

Overview Company News Filings

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-20

Wall Street Analysts Are Bullish on Top Healthcare Picks

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

Royalty Pharma EVP and Chairman of Partnering Christopher Hite Sells 100,000 Shares for $6 Million

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

Why 2026 is Biotech's Comeback Year

Alnylam Pharmaceuticals Shares up 5.2% After Bmo Initiates Coverage with Outperform Rating

THOMSON REUTERS

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS

Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PBE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":98.7315,"timestamp":1787688000000,"preClose":97.301,"halted":0,"volume":6544,"hourTrading":{"tag":"盘后","latestPrice":98.685,"preClose":98.7315,"latestTime":"19:30 EDT","volume":11,"amount":1086.1635,"timestamp":1787700601847,"change":-0.0465,"changeRate":-0.000471,"amplitude":0},"delay":0,"changeRate":0.014701801625882518,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Not Yet Opened","change":1.4305,"latestTime":"08-25 16:00:00 EDT","open":97.68,"high":98.82,"low":97.68,"amount":644330.0273600001,"amplitude":0.011716,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":97.301,"sharesOutstanding":3180000,"nav":97.25464,"aum":401661663.2,"dividendRate":0.01567,"bidAskSpread":0.002967,"postHourTrading":{"tag":"盘后","latestPrice":98.685,"preClose":98.7315,"latestTime":"19:30 EDT","volume":11,"amount":1086.1635,"timestamp":1787700601847,"change":-0.0465,"changeRate":-0.000471,"amplitude":0},"volumeRatio":0.281845,"impliedVol":0.1495,"impliedVolPercentile":0.0757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.281845,"shares":4120000,"dividePrice":1.5471,"high":98.82,"amplitude":0.011716,"preClose":97.301,"low":97.68,"week52Low":67.56,"pbRate":"1.64","psRate":"236.96","week52High":98.82,"institutionHeld":0.2552,"latestPrice":98.7315,"eps":1.793292,"divideRate":0.01567,"volume":6544,"delay":0,"ttmEps":1.793292,"open":97.68,"prevYearClose":82.15,"prevWeekClose":97.59,"prevMonthClose":89.6108,"prevQuarterClose":89.6486,"fiveDayClose":95.28,"twentyDayClose":91.7375,"sixtyDayClose":83.8038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661294871","title":"Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294871?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787330033,"startTime":"0","endTime":"0","summary":"Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. has launched a Phase 2 trial testing felzartamab in adults wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogen-expands-autoimmune-pipeline-with-new-graves-disease-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogen-expands-autoimmune-pipeline-with-new-graves-disease-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","BK4532","BBC","LU0320765992.SGD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0109394709.USD","LU0234570918.USD","PSIL","PBE","BK4139","BK4588","BK4585","LU0889565916.HKD","IE00B894F039.SGD","BIIB","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661523754","title":"Biogen Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661523754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661523754?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:56","pubTimestamp":1787259360,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slid 3.25% to $214.35 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a two-day winning streak.Biogen Inc. closed 3.51% short of its 52-week high of $222.15, which the company achieved on August 19th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and AbbVie Inc.  fell 1.56% to $261.83.Trading volume  remained 414,428 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","BK4532","BK4139","BIIB","BK4588","LU0320765992.SGD","BK4585","IE00B894F039.SGD","BK4533","BMED","LU0109394709.USD","LU0234570918.USD","IE00B19Z9P08.USD","LU0889565916.HKD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","IE00B2B36J28.USD","LU1815336091.USD","IE0002141913.USD","LU2456880835.USD","LU2324357040.USD","IBBQ","LU2362541513.USD","BBH","SG9999001176.USD","LU0757428866.USD","TBXU","VERX","BIB","BK4588","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU1069344957.HKD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU2237438978.USD","IBB","GNMX","LU1093756325.SGD","IDNA","LU0566484027.USD","SGXZ57979304.SGD","LU0289739699.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU2417539215.USD","IE0009355771.USD","LU2362540622.SGD","SG9999013999.USD","LU0889565916.HKD","BK4139","LU0256863811.USD","PBE","LU1093756168.USD","IE00B894F039.SGD","SG9999001176.SGD","VRTX","BK4567","LU0432979614.USD","LU2362541273.HKD","LU0079474960.USD","IE00B19Z3581.USD","LU2089984988.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660336672","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-20","url":"https://stock-news.laohu8.com/highlight/detail?id=2660336672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660336672?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:01","pubTimestamp":1787238067,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-08-20Nasdaq 100.NDXTop PerformersPercent ChangeStrategy IncMSTR.OQ+5.4%Lumentum Holdings Inc.LITE.OQ+4.4%Seagate Technology Holdings PLCSTX.OQ+3.8%Marvell Technology, Inc.MRVL.OQ+3.3%Diamondback Energy, Inc.FANG.OQ+2.9%Bottom PerformersPercent ChangeWalmart IncWMT.OQ-9.6%Space Exploration Technologies CorpSPCX.OQ-4.8%Alnylam Pharmaceuticals, Inc.ALNY.OQ-3.6%CrowdStrike Holdings, Inc.CRWD.OQ-3.2%Tesla IncTSLA.OQ-3.0%The Nasdaq 100.NDXlost 109.43 points, or 0.37%, to 29,316.59 and recorded one new high and no new lows. 51 stocks rose and 50 fell as advancing issues outnumbered decliners by a about a 1-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL8N44H186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1235294995.USD","BK4213","BK4600","LU0154236417.USD","LU0061475181.USD","LU1951198990.SGD","ARTY","LU1066051225.USD","LU1429558221.USD","LU2430703178.SGD","LU0553294199.USD","LU1084165304.USD","LU0109391861.USD","LU1720051017.SGD","IE00BN8TJ469.HKD","IE00B3CCJ963.GBP","LU2458330169.SGD","LU1066051811.HKD","LU0234572021.USD","07522","SG9999015986.USD","IE0001KFT4U8.USD","LU0889565916.HKD","IE00B894F039.SGD","LU0320765992.SGD","LU0274383776.USD","BK4534","BK4139","LU0820562030.AUD","LU2213496289.HKD","07399","LU0345770308.USD","07799","07266","CRWL","BK4141","IE0004091025.USD","LU2462157665.USD","TSLW","BK4605","BK4504","MSTY.UK","BK4023","TSLP","BK4581","LU0511384066.AUD","LU2505996509.AUD","SMOG","LU1861559042.SGD","LU1804176565.USD","LU2430703095.HKD","LU1232071149.USD","LU2322448957.HKD","TSLR","LU0323591593.USD","LU1674673691.USD","BK4528","LU1366192091.USD","BK4574","LU1983260115.SGD","LU0097036916.USD","LU0545039389.USD","IGV","HXC","03455","LU2125154778.USD","LU0823414478.USD","LU0738911758.USD","LU1992135472.HKD",".HXC","LU2168563687.JPY","LU1435385759.SGD","NJUL","TQQQ","CRWD","LU2357305700.SGD","TSLL","LU0823434583.USD","LU2326559502.SGD","LU1670627923.USD","LU0314104364.USD","TSYY","BK4555","LU1989764664.SGD","IE000M9KFDE8.USD","IE00BMPRXQ63.HKD","PSWD","IE0034235188.USD","WLDR","IE0004086264.USD","LU0310799852.SGD","HK0000914686.HKD","QQQG","LU2361045086.USD","LU0719512351.SGD","LU1720051108.HKD","ALNY","LU0081259029.USD","09086","LU2403377893.USD","BK4612","RTH","LU2265009873.SGD","LU2168564065.EUR","LU1670628061.USD","LU1861215975.USD","WMT","LU1064131342.USD","DTCR","LU1316542783.SGD","LU0316494557.USD","QID","BK4515","LU1778281490.HKD","IE00BK4W5M84.HKD","FCUS","LU2106854487.HKD","BK4551","BK4592","LU0320765059.SGD","IE00BSNM7G36.USD","LU0149725797.USD","LU0820561909.HKD","LU2471134796.USD","LU1303367103.USD","BK4532","LU1814569148.SGD","LU2602419157.SGD","SG9999015978.USD","LITG","BK4560","LU0823421416.USD","LU0211328371.USD","LU0203347892.USD","LU0265550946.USD","IE00B1XK9C88.USD","LU0238689110.USD","LU1169589451.USD","MSTW","LU0353189763.USD","LU1989764748.USD","FDTX","TSLA","SG9999015945.SGD","3SMI.UK","LU0466842654.USD","LU2097829019.USD","LU0127658192.USD","LU1066053197.SGD","LU0957808578.USD","MSDD","BK4512","LU1267930490.SGD","LU1861558580.USD","MRVL","LU0708995401.HKD","LU2290526834.HKD","LU0957791311.USD","NAPR","IE00BLSP4452.SGD","GB00BDT5M118.USD","LU1116320901.HKD","IE00BZ9MQY76.HKD","LU2360032135.SGD","LU2360106780.USD","SMI3.UK","LITX","LU1551013425.SGD","EGGY","LU0823421333.USD","IE0034235303.USD","AIFD","LU2125154935.USD","LU2473716301.USD","LU2360107168.USD","FSTA","QQQM","LU0823411888.USD","LU2168564222.USD","LU0348723411.USD","DRMY","MSTR","03034","LU2168564495.EUR","LU2746668461.USD","TQQY","BK4099","LU0077335932.USD","MRVU","LU1261432733.SGD","LU0211327993.USD","LU2461242641.AUD","LU0345769128.USD","LU2430703251.USD","QMAR","SG9999000418.SGD","LU1119994496.HKD","LU0205193047.USD","03086","STX","NJAN","LU0256863902.USD","LU1815333072.USD","LU0444971666.USD","WCBR","LU0345769631.USD","BK4598","LU1551013342.USD","BK4604","LU1923622614.USD","07366","LU2294711713.HKD","LU2433249047.HKD","LU0203345920.USD","BK4543","IE00BMPRXR70.SGD","LU1815336760.USD","LU2125909247.SGD","HK0000819398.USD","LU2746668974.SGD","QQQX","STSLAmain","TRUO","LAZR","LU1548497426.USD","LU2125909916.SGD","LU0742534661.SGD","LU2286300806.USD","LU2417539215.USD","LU2250418816.HKD","OILT","SQQQ","LU0949170772.SGD","LU0417517546.SGD","LU1951200564.SGD","ELOL","LU1035773651.USD","LU1046421795.USD","LU0265550359.USD","MSOO","07766",".IXIC","HK0000914660.USD","LU0234570918.USD","LU2023250330.USD","LU0133085943.USD","LU2125909759.SGD","FXL","LU2931357623.SGD","LU1839511570.USD","IE00B19Z9Z06.USD","LU1923623000.USD","BK4588","NDX","WATS","MSII","LU1267930730.SGD","NOCT","APED","LU0240877869.USD","LU2471134952.CNY","LU1430594728.SGD","SPAM","TEST","RULE","LU0289961442.SGD","LU0661504455.SGD","TSLG","LU1629891620.HKD","LU1974910355.USD","LU1145028129.USD","BK4596","MSST","LU0096362180.USD","LU2361044949.HKD","LU0345770993.USD","MSTZ","LU1923622291.USD","CIBR","LU1674673428.USD","LU2357125470.USD","LUMA","MSTU","MSTX","TSII","IE00BBT3K403.USD","TESL","LU2098885051.SGD","LU1069347547.HKD","TSLY","QQQ","QDEC","LU0689472784.USD","LU0187121727.USD","LU2211815571.USD","MVLL","TEXX","BK4170","LU2756315664.SGD","LMI3.UK","LU2896262040.SGD","LU2249611893.SGD","LU2023250504.SGD","LU0820561818.USD","LU0061474960.USD","XNTK","02834","LU0289739343.SGD","BK4548","MSTY","HAKY","LU2236285917.USD","TSLQ","CRSH","LU2750360997.AUD","SG9999015952.SGD","LU2381873111.SGD","LU2264538146.SGD","IMST","LU0210536198.USD","IE00B19Z9505.USD","LU2456880835.USD","LU1988902786.USD","LU2756315318.SGD","BITQ","LU0476273544.USD","WUGI","BK4097","LU0205194284.USD","WANT","LU2471134879.HKD","WNTR","MSTP","LU0672654240.SGD","TSLS","DISK","TSLO","FANG","LU2506951792.HKD","MST","LU2087621335.USD","BK4511","MSTK","LU0289960550.SGD","LU2592432038.USD","LU0964807845.USD","BK4597","09834","CRPT","LU2244417387.USD","LITE","LU1116320737.USD","FOTO","LU0048573561.USD","IE00B19Z8X17.USD","LU2168564149.EUR","TSLI","LU2125909593.SGD","LU1992135399.USD","LU0109394709.USD","LU0823414551.USD","LU0882574055.USD","BK4020","MRVX","LU2420271590.USD","LU0082616367.USD","LU0266013472.USD","UGE","LU1917777945.USD","LU0198837287.USD","TSL","QQQA","QLD","LU1861220033.SGD","IE00BLSP4239.USD","LU0251131958.USD","TSLZ","IE00BMPRXN33.USD","MTYY","LU2089985449.USD","LU0106261612.USD","IE00B2Q91V27.USD","TSDD","LIT","AIS","LU2272731600.USD","LU0053666078.USD","LU0353189680.USD","LU1169590202.USD","GNMX","LU1823568750.SGD","07261","BK4595","SMST","PBE","IE00BJLML261.HKD","BUG","LU2108987350.USD","BK4550","LU0786609619.USD","LU2087625088.SGD","BK4533","OWNB","07568","BK4585","LU0175139822.USD","LU2543165471.USD","GPIQ","IE00B19Z8W00.USD","LU2458330243.SGD","LU0640476718.USD","LU1066051498.USD","IE00BK4W5L77.USD","09799","LU2063271972.USD","LU0642271901.SGD","FAI","LU1585245621.USD","09366","PSQ","LU0240878834.USD","LU1280957306.USD","LU0114720955.EUR","SOXY","IDRV","CLOD","09399","LU0012050646.USD","09766","LU1003077747.HKD","IE00BWXC8680.SGD","CRWC","LU2272731865.HKD","GTEK","AIPI","LU0256863811.USD","LU1914381329.SGD","XLP","3LMI.UK","IE00B19Z9P08.USD","LU2750360641.GBP","LU0943347566.SGD","FTXL","LU0056508442.USD","TLA","FDRV","TSLT","LU1852331112.SGD","LU1642822529.SGD","IE00B1BXHZ80.USD","BK4155","IE00BGHQF524.EUR","LU0444973449.USD","LU0823434740.USD","BK4516","LU2505996681.GBP","SMHX","WMTI","LU2361044865.SGD","BK4527","LU2322448791.USD","LU2471134523.USD","LU2272731782.SGD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU2462157665.USD","BK4585","BBH","GNMX","IE0002270589.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU1878469433.USD","PBE","LU1674673428.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","IBBQ","LU0109394709.USD","IE00B19Z3B42.SGD","LU2362541513.USD","LU2417539215.USD","LU2468319806.SGD","SG9999001176.USD","BK4548","LU2456880835.USD","VRTX","BK4082","LU1585245621.USD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","LU0889565916.HKD","LU1674673691.USD","LU0079474960.USD","LU1069344957.HKD","LU0432979614.USD","LU1430594728.SGD","SG9999001176.SGD","BK4588","LU0823416689.USD","IE0002141913.USD","IDNA","LU2362541273.HKD","LU0256863811.USD","BK4532","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU0058720904.USD","LU2236285917.USD","TBXU","IE0009354923.USD","IE0009355771.USD","LU2089984988.USD","LU0289739699.SGD","SG9999013999.USD","IBB","IE00B19Z9P08.USD","LU0320765992.SGD","BK4533","BIB","LU2065731478.USD","GKOS","LU2324357040.USD","LU0234570918.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","BK4567","IE00B19Z9Z06.USD","LU1093756168.USD","LU2362540622.SGD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660567400","title":"Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660567400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660567400?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:24","pubTimestamp":1787217854,"startTime":"0","endTime":"0","summary":"Insight Guru says Health Care dominates mid-cap 52-week highs list, with 11 of 19 names at new peaksInsight Guru flagged 19 Russell 3000 mid-cap stocks at 52-week highs, led by Biogen at about USD 32.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL1XGRhX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH","BK4550","BK4533","BK4585","LU1059921491.USD","PBE","LU0109394709.USD","LU0048573561.USD","LU0251142724.SGD","LU0320765992.SGD","LU0234570918.USD","LU0251131958.USD","BK4588","LU0889565916.HKD","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0006061336.USD","BK4139","LU2237438978.USD","BK4532","BIIB","IE00B19Z9Z06.USD","BMED","LU0742534661.SGD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE0009355771.USD","IBB","BK1515","IE00BZ08YT58.USD","BBH","BK4534","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4588","BK1589","LU2112291526.USD","LU2468319806.SGD","LU0889565916.HKD","IE00BJT1NW94.SGD","BIB","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4599","PJP","LU0122379950.USD","SG9999001440.SGD","01177","BK4566","LU0109394709.USD","HK0000165453.HKD","IE0002141913.USD","IE00B2B36J28.USD","IBBQ","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","LU0320765992.SGD","BK4581","BK4585","LU2242652126.USD","BK1191","IE00BZ08YR35.GBP","LU2242646821.SGD","AMGN","BK1521","LU0868494617.USD","IE00BZ08YS42.EUR","TBXU","LU1571399168.USD","PBE","LU1983299246.USD","BK4533","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU0889565916.HKD","IDNA","IBB","IE0002141913.USD","LU0566484027.USD","GNMX","VRTX","LU2462157665.USD","BK4588","LU0320765992.SGD","SG9999013999.USD","VERX","LU2362541513.USD","SGXZ57979304.SGD","PBE","LU0234570918.USD","LU1093756168.USD","IE00B19Z9Z06.USD","LU0289739699.SGD","LU0061475181.USD","BK4533","LU0058720904.USD","IE00BZ9MQY76.HKD","SG9999001176.SGD","IBBQ","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","BK4585","IE0009355771.USD","TBXU","IE00BJT1NW94.SGD","LU2456880835.USD","IE0002270589.USD","LU1035775433.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU2236285917.USD","SG9999001176.USD","LU1093756325.SGD","BK4023","IE00B19Z9P08.USD","BBH","BIB","LU2237438978.USD","LU2468319806.SGD","LU2089984988.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479247","title":"Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479247?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:29","pubTimestamp":1787182181,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals released an interim H1 2026 results presentation outlining...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FDIF","TLX","GNOM","IDNA","LFSC","XT","TMAT","WDNA","BK4139","BMED","PBE","HELX","GNMX","SYNB","GDOC","IBB","MEDX","JDOC","BK4588","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","IE00B19Z3581.USD","BK4139","BK4588","LU0061475181.USD","LU1035775433.USD","SPHQ","IE00B4R5TH58.HKD","LU1674673428.USD","VERX","BK4533","LU2089984988.USD","IDNA","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","LU2468319806.SGD","VRTX","SG9999013999.USD","LU0320765992.SGD","LU0256863811.USD","IBBQ","LU1069344957.HKD","LU2462157665.USD","IE00B2B36J28.USD","TBXU","SG9999001176.SGD","LU0566484027.USD","PBE","IE00BJT1NW94.SGD","IE00B894F039.SGD","LU0432979614.USD","IBB","LU0889565916.HKD","GNMX","LU0058720904.USD","LU2456880835.USD","BK4532","LU1815336091.USD","LU0417517546.SGD","LU0757428866.USD","BBH","LU0823416689.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","BIB","LU0109394709.USD","SG9999001176.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU0432979614.USD","IE00B19Z9P08.USD","BK4139","IE00B19Z3581.USD","LU1674673691.USD","PBE","SGXZ57979304.SGD","IBB","LU0289739699.SGD","LU2089984988.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","TBXU","IE00B894F039.SGD","IE0002141913.USD","BIB","IBBQ","IE00B2B36J28.USD","LU2417539215.USD","LU2362541513.USD","BBH","LU1778281490.HKD","IE00BZ9MQY76.HKD","LU0320765992.SGD","LU1815336091.USD","BK4585","IDNA","LU1035775433.USD","IE00B19Z9Z06.USD","SG9999001176.SGD","LU2324357040.USD","LU2456880835.USD","LU1585245621.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SG9999013999.USD","IE00B4R5TH58.HKD","LU2462157665.USD","BK4567","LU1093756168.USD","VERX","BK4588","BK4533","LU0566484027.USD","LU0234570918.USD","LU1069344957.HKD","SG9999001176.USD","GNMX","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473300","title":"Royalty Pharma EVP and Chairman of Partnering Christopher Hite Sells 100,000 Shares for $6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473300","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473300?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:21","pubTimestamp":1787170905,"startTime":"0","endTime":"0","summary":"Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 millionRoyalty Pharma EVP and Chairman, Partnering Christopher Hite sold 100,000 Class A Ordinary Shares on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLX6jg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP and Chairman of Partnering Christopher Hite Sells 100,000 Shares for $6 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PBE","IHE","RPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473673","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473673","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473673?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:15","pubTimestamp":1787170546,"startTime":"0","endTime":"0","summary":"• Vertex stock surged to record highs following a rival's clinical trial failure.\n• Q2 revenue beat estimates, and the company raised its full-year guidance.\n• Analysts issued bullish ratings with an average price target of $563.25.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262119122-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2362541513.USD","PBE","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU2324357040.USD","IE00B894F039.SGD","SG9999001176.USD","BK4585","TBXU","LU1674673691.USD","BK4567","LU0889565916.HKD","LU1093756325.SGD","BBH","IBBQ","IE00BZ9MQY76.HKD","LU0061475181.USD","LU2236285917.USD","SGXZ57979304.SGD","LU0432979614.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","LU2417539215.USD","IE00B19Z3B42.SGD","BIB","VRTX","IE00B19Z3581.USD","LU0823416689.USD","LU2237438978.USD","LU2362541273.HKD","IE0002270589.USD","LU2462157665.USD","LU2362540622.SGD","IDNA","LU1585245621.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1035775433.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","IE00B19Z9P08.USD","BK4533","IE00B2B36J28.USD","LU1778281490.HKD","LU0417517546.SGD","LU2456880835.USD","BK4532","BK4588","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","LU2089984988.USD","GNMX","IBB","IE00BJT1NW94.SGD","LU0109394709.USD","LU0289739699.SGD","LU0058720904.USD","LU1069344957.HKD","LU1093756168.USD","LU0079474960.USD","SG9999001176.SGD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420810","title":"Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420810","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660420810?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:15","pubTimestamp":1787163346,"startTime":"0","endTime":"0","summary":"• Argus raised Amgen's price target and reiterated a Buy rating.\n• Second-quarter financial performance exceeded Wall Street revenue and earnings expectations.\n• Technical indicators show a MACD buy signal and RSI buy condition.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118745-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0889565916.HKD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","PBE","LU2089984988.USD","TBXU","LU1061106388.HKD","BBH","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","04332","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421798","title":"Why 2026 is Biotech's Comeback Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421798","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421798?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:16","pubTimestamp":1787152560,"startTime":"0","endTime":"0","summary":"This article was originally published on April 1, 2026. It has been updated to reflect recent developments.After a rough past few years, the biotech sector looks to be turning a corner. Major pharmace","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1691799644.USD","BK4534","XLV","LU1280957306.USD","PBE","LU2168564495.EUR","LU2324357040.USD","LU2112291526.USD","LU2746668461.USD","LU1267930730.SGD","THNR","WDNA","LLII","LU0820562030.AUD","LU0889565916.HKD","LU0061475181.USD","IBBQ","LU0354030438.USD","LU2271345857.HKD","SGXZ57979304.SGD","LU0109391861.USD","IE0004445239.USD","IE00BWXC8680.SGD","SG9999014906.USD","LU1232071149.USD","LU2089283258.USD","IE00BN29S564.USD","IE00B4JS1V06.HKD","LU2237438978.USD","SGXZ81514606.USD","LU1551013342.USD","MRNY","GDOC","BK4566","LU0097036916.USD","IE00B1BXHZ80.USD","LU1629891620.HKD","LU2237443549.SGD","SG9999018865.SGD","LU1720051017.SGD","LU2237443465.HKD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU2237443895.HKD","LU2264538146.SGD","HRTS","LU1127390331.HKD","LU1291159041.SGD","SG9999014880.SGD","IE0005OL40V9.USD","LU0106261372.USD","LU2168564149.EUR","LU2265009873.SGD","IYH","LU0198837287.USD","LU2237443382.USD","LU2750360997.AUD","LU1868836914.USD","LU2471134796.USD","IBB","LU1069344957.HKD","LU0256863902.USD","LU1712237335.SGD","IE0001KFT4U8.USD","TMED","SG9999013999.USD","LU0203202063.USD","LLYZ","LU2471134523.USD","IE0004445015.USD","SG9999017495.SGD","AMGN","RXL","LU1064131342.USD","FTXH","LU2168564222.USD","PJP","LU0672654240.SGD","LU2462591350.SGD","LU2360106947.USD","OZEM","LU0689472784.USD","LU1974910355.USD","LU0225283273.USD","LU2417539215.USD","LU2211815571.USD","LU1988902786.USD","BIB","SG9999015986.USD","LU2023250330.USD","BK4551","BK4568","IE00BK4W5L77.USD","LU2237443622.USD","LU0943347566.SGD","LU0114720955.EUR","LU0823416689.USD","LU0964807845.USD","LU2602419157.SGD","LU0154236417.USD","LU0385154629.USD","LU2491049909.HKD","NVOH","BK4599","BK4501","LU2462157665.USD","ELIS","LU0353189763.USD","IE00BK4W5M84.HKD","LU1868837300.USD","LU2028103732.USD","LU0316494557.USD","LU2491050071.SGD","BK4548","LU2213496289.HKD","IE00BJJMRY28.SGD","LU0823434583.USD","SG9999014914.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU0203201768.USD","BK4532","LU2063271972.USD","IXJ","LU0345770308.USD","LU0882574055.USD","LU1323610961.USD","IE00BJT1NW94.SGD","CANC","LU0109394709.USD","LU1093756168.USD","LU0708995401.HKD","LU2089284900.SGD","LU0882574139.USD","LU2106854487.HKD","SG9999001176.SGD","SGXZ31699556.SGD","LU2461242641.AUD","IE00BJJMRX11.SGD","MRNA","CURE","JDOC","04332","AGNG","LU2108987350.USD","LU2756315318.SGD","LU0158827781.USD","NVO","TRUH","LU0133085943.USD","TBXU","BK4585","LU1366192091.USD","LU0466842654.USD","LU2242652126.USD","LU2552382058.USD","LU1868837136.USD","LU0323591593.USD","VHT","LU2168563687.JPY","MHIP","LU1057294990.SGD","LU2023250504.SGD","IE00B7KXQ091.USD","LU2168564065.EUR","LU2361044949.HKD","MEDI","LU1551013425.SGD","BK4007","IE00BKVL7J92.USD","LU1720051108.HKD","LU0266013472.USD","LU2552382215.SGD","LU0456855351.SGD","SG9999014898.SGD","IE00B1XK9C88.USD","LU2242646821.SGD","LU1145028129.USD","LU1035775433.USD","LGHT","IE00BZ1G4Q59.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU2237443978.SGD","BK4533","LU0471298777.SGD","LU0787776722.HKD","LU0868494617.USD","LU1571399168.USD","LU2491050154.USD","ILDR","LLY","LU0122379950.USD","LU0417517546.SGD","LU0238689110.USD","LU2456880835.USD","LU2552382132.HKD","LU1023059063.AUD","LU2361044865.SGD","LU0058720904.USD","IE00B775H168.HKD","LU2471134879.HKD","LU0079474960.USD","LU0158827948.USD","MEDX","LU0683600562.USD","PPH","LU2896262040.SGD","SG9999015945.SGD","LU0320765992.SGD","LU1868836757.USD","LU0345770993.USD","LU2357305700.SGD","LU2111349929.HKD","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU0234572021.USD","SG9999001176.USD","SGXZ99366536.SGD","LLYX","LU0006306889.USD","LU2361045086.USD","LU0320765059.SGD","IHE","LU1093756325.SGD","BBH","LU2087625088.SGD","LU0354030511.USD","LU2750360641.GBP","NVOX","LU2236285917.USD","LU0094547139.USD","SG9999015952.SGD","LU1989771016.USD","LU0432979614.USD","LU1548497426.USD","LU1804176565.USD","LU2756315664.SGD","LU0174119429.USD","FHLC","LU1623119135.USD","IE00BFSS7M15.SGD","LU0640476718.USD","GB00BDT5M118.USD","LU0786609619.USD","LU2023251221.USD","LU1979441026.SGD","IDNA","LU1814569148.SGD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","GNOM","LU1983299246.USD","SG9999015978.USD","ELIL","IE00B2B36J28.USD","SG9999018857.SGD","SGXZ51526630.SGD","LU0471298694.HKD","BK4588","LU0353189680.USD","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","LU0820561818.USD","LU0289739699.SGD","LU1868836591.USD","MRNX","SG9999001440.SGD","LU1061106388.HKD","LU0210536198.USD","LU2471134952.CNY","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426197","title":"Alnylam Pharmaceuticals Shares up 5.2% After Bmo Initiates Coverage with Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426197?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:56","pubTimestamp":1787147810,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G15Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","ALNY","BK4585","LU0109394709.USD","PBE","LU0882574055.USD","GNMX","BK4548","BK4588","LU0320765992.SGD","LU0114720955.EUR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426691","title":"Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426691?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:45","pubTimestamp":1787147100,"startTime":"0","endTime":"0","summary":"DJ Merck, Amgen Share Gains Contribute To Dow's 161-Point ClimbThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck and Amgen are posting positive gains Wednesday morning, lifting the Dow Jones Industrial Average into positive territory.Shares of Merck  and Amgen  have contributed to the blue-chip gauge's intraday rally, as the Dow  was most recently trading 161 points higher .Merck's shares have climbed $12.37  while those of Amgen are up $13.30 , combining for an approximately 153-point bump for the Dow.Other components contributing significantly to the gain include Sherwin-Williams Co. , Home Depot , and Salesforce .A $1 move in any one of the 30 components of the benchmark results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDOW","04332","LU0106261372.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU1066051811.HKD","LU0203345920.USD","BIB","LU1585245621.USD","LU1116320901.HKD","SG9999001440.SGD","XLV","IE00BLSP4452.SGD","JDOC","LU0859254822.USD","LU2491050071.SGD","MGK","LU1974910355.USD","LU0265550946.USD","LU1037948541.HKD","LU0320765992.SGD","SDY","LU0320765489.SGD","LU2089984988.USD","LU2491050154.USD","LU0823416689.USD","LU1989772923.USD","PPH","LU0070302665.USD","AMGN","LU2361045086.USD","LU1989772840.SGD","LU1917777945.USD","YMAX","LU2106854487.HKD","LU2360032135.SGD","LU1934455277.USD","LU0689626769.HKD","IE00BSNM7G36.USD","LU1093756168.USD","RXL","XLI","LU2242652126.USD","MYMmain","DJIA","SG9999014567.USD","LU0942090050.USD","LU1983299246.USD","LU0965509283.SGD","LU0130102774.USD","IE00BLSP4239.USD","BK4534","LU0109394709.USD","LU2125154935.USD","DVY","LU1066051225.USD","LU0130517989.USD","TBXU","LU2023250504.SGD","DGRO","LU0203347892.USD","DOG","LU1061106388.HKD","VYMI","BK4581","TOPT","LU0265550359.USD","LU0985320562.USD","IE00BFTCPJ56.SGD","SCHD","LU0266013472.USD","LU1023059063.AUD",".DJI","IE00B1BXHZ80.USD","PBE","LU0648001328.SGD","LU0122379950.USD","LU1035773651.USD","FDN","DDM","SG9999001176.SGD","LU1989771016.USD","LU2433249047.HKD","SG9999014575.USD","SG9999002232.USD","IE00B4R5TH58.HKD","SG9999015341.SGD","LU1201861249.SGD","IXJ","LU0211331839.USD","LU2112291526.USD","SG9999002224.SGD","LU1923622614.USD","IYH","BMED","SG9999015358.SGD","LU0289739699.SGD","BK4559","BK4566","SCHG","DXD","IE00BJT1NW94.SGD","LU0868494708.USD","LU2361044865.SGD","HRTS","SDOW","VYM","PAWZ","LU1162221912.USD","LU1941712348.USD","PJP","BK4599","GRNY","BK4588","LU1934455863.HKD","SGXZ57979304.SGD","MRK","IHE","LU1699723380.USD","BK4139","DGRW","LU1093756325.SGD","VUG","LU0006306889.USD","LU2491049909.HKD","DIA","LU0124676726.USD","LU2468319806.SGD","LU0477156953.USD","IBB","LU2023250843.SGD","IE00BBT3K403.USD","BK4533","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","FDVV","BK4550","BK4585","LU1571399168.USD","LU1037948897.HKD","LU2361044949.HKD","VHT","LU2357627491.SGD","SG9999001176.USD","LU1291159041.SGD","SG9999014542.SGD","FHLC","LU0980610538.SGD","LU1929549753.HKD","LU2461242641.AUD","TRUH","BK4516","IBBQ","LU0238689110.USD","LU0320765646.SGD","LU0432979614.USD","LU1116320737.USD","BBH","LU2242646821.SGD","BK4007","IE00B2B36J28.USD","LU1430594728.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1069347547.HKD","IE0009355771.USD","LU1934455194.USD","DJX","SG9999013999.USD","LU0965509010.AUD","LU0098860793.USD","LU1941712264.USD","LU0058720904.USD","FTXH","LU0889565916.HKD","LU2125154778.USD","IE0002141913.USD","LU2324357040.USD","LU2125909593.SGD","LU2125909247.SGD","IE00BN8TJ469.HKD","GDOC","LU0234572021.USD","SG9999014559.SGD","LU0965509101.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142854","title":"BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142854?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:04","pubTimestamp":1787141066,"startTime":"0","endTime":"0","summary":"BetterLife Pharma names Mahan Chehrenama chief medical officerBetterLife Pharma named Mahan Chehrenama as chief medical officer to lead clinical development of BETR-001.BETR-001 is advancing toward an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL40h7WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0058720904.USD","IBB","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0122379950.USD","BK4588","IE00B4R5TH58.HKD","PJP","IE00BJJMRZ35.SGD","LU2242652126.USD","TBXU","SG9999001440.SGD","BBH","LU1061106388.HKD","AMGN","LU1571399168.USD","BK4581","BK4566","LU1057294990.SGD","BIB","IE0002141913.USD","LU0289739699.SGD","IBBQ","BK4599","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0320765992.SGD","LU2242646821.SGD","LU2468319806.SGD","LU2112291526.USD","LU0109394709.USD","PBE","BK4534","LU1983299246.USD","IE0009355771.USD","BK4139","LU0868494617.USD","BK4533","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344705","title":"Amgen Inc : Argus Research Raises Target Price to $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344705?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:25","pubTimestamp":1787138742,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU1571399168.USD","LU1023059063.AUD","TBXU","BK4581","BK4139","IE00BFTCPJ56.SGD","BK4534","LU2112291526.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4588","PJP","LU2242652126.USD","LU0868494617.USD","SG9999001440.SGD","IBB","LU0122379950.USD","BK4566","LU2089984988.USD","BK4533","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BIB","BK4585","LU1061106388.HKD","LU1983299246.USD","LU2242646821.SGD","PBE","LU0320765992.SGD","LU0058720904.USD","LU1057294990.SGD","AMGN","LU0289739699.SGD","IE0009355771.USD","BK4599","IE0002141913.USD","IBBQ","IE00BJJMRZ35.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184678054","title":"Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184678054","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184678054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:15","pubTimestamp":1787127336,"startTime":"0","endTime":"0","summary":"Andy Acker, Portfolio Manager for healthcare and biotech strategies at Janus Henderson Investors, notes that despite interest rates remaining higher than markets anticipated at the start of the year,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BBC","BIB","BK4585","GTPE","MRNX","PBE","BBP","IYG","IAI","JDOC","MRNY","FBT","IWO","IJT","BK4582","SPCK","IBBJ","BK4588","QSML","BIS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}